Resources

Results per page

Selected Filters:

Drug Discovery & Development Clear Filters

Application Notes

A flexible approach to bioanalysis

9 Jan 2023

Application Notes

Case study: Efficiently performing two global approval studies in prostate cancer patients

9 Jan 2023

Application Notes

A flexible approach to early phase clinical trials

9 Jan 2023

Application Notes

A flexible approach to global regulatory affairs

9 Jan 2023

Application Notes

A flexible approach to neuropharmacology

9 Jan 2023

Application Notes

A flexible approach to phase II-IV clinical trials

9 Jan 2023

Application Notes

A flexible approach to toxicology and preclinical services

9 Jan 2023

White Papers

Antibody drug conjugates

9 Jan 2023

White Papers

CNS drug development

9 Jan 2023

White Papers

Five criteria to use when selecting a CRO for a gene therapy study

9 Jan 2023

White Papers

Human AME (mass balance) studies

9 Jan 2023

White Papers

Selecting the location of a phase I clinical trial site for EU registration

9 Jan 2023

White Papers

Pharmacokinetic studies in patients

9 Jan 2023

White Papers

Plasma protein binding

9 Jan 2023

White Papers

RNAi therapeutics

9 Jan 2023

White Papers

Three lessons to help accelerate pharmaceutical breakthroughs for CNS disorders

9 Jan 2023

White Papers

Regulatory considerations in gene and cellular therapy development

9 Jan 2023

White Papers

Therapeutic oligonucleotide metabolite identification, profiling, and quantitation

9 Jan 2023

Application Notes

A flexible approach to biotherapeutics and vaccines

6 Jan 2023

Application eBooks

The art behind good filtration: How to get the best out of filtration

9 Dec 2022

Application Notes

RNA therapeutics: A revolution empowered by ddPCR™ technology

7 Nov 2022

Application eBooks

Automating cell line development for biologics: A complete guide

23 Oct 2022

Application Notes

Effectiveness of CRISPR-Cas9 using pools of Dharmacon Edit-R synthetic crRNAs in high-content analysis screening experiments

21 Aug 2022

Application Notes

The Dual Screen: Parallel genome-wide CRISPRi & CRISPRa screening

21 Aug 2022

Application Notes

Pooled Phenotypic CRISPR Screening enables the identification of synergistic drug combinations for cancer therapy

21 Aug 2022

Resources

Resources Filter

Search

Selected Filters:

A flexible approach to bioanalysis

Case study: Efficiently performing two global approval studies in prostate cancer patients

A flexible approach to early phase clinical trials

A flexible approach to global regulatory affairs

A flexible approach to neuropharmacology

A flexible approach to phase II-IV clinical trials

A flexible approach to toxicology and preclinical services

Antibody drug conjugates

CNS drug development

Five criteria to use when selecting a CRO for a gene therapy study

Human AME (mass balance) studies

Selecting the location of a phase I clinical trial site for EU registration

Pharmacokinetic studies in patients

Plasma protein binding

RNAi therapeutics

Three lessons to help accelerate pharmaceutical breakthroughs for CNS disorders

Regulatory considerations in gene and cellular therapy development

Therapeutic oligonucleotide metabolite identification, profiling, and quantitation

A flexible approach to biotherapeutics and vaccines

The art behind good filtration: How to get the best out of filtration

RNA therapeutics: A revolution empowered by ddPCR™ technology

Automating cell line development for biologics: A complete guide

Effectiveness of CRISPR-Cas9 using pools of Dharmacon Edit-R synthetic crRNAs in high-content analysis screening experiments

The Dual Screen: Parallel genome-wide CRISPRi & CRISPRa screening

Pooled Phenotypic CRISPR Screening enables the identification of synergistic drug combinations for cancer therapy

Resources

Resources FilterResources Filter

Search

Selected Filters:

A flexible approach to bioanalysis

Case study: Efficiently performing two global approval studies in prostate cancer patients

A flexible approach to early phase clinical trials

A flexible approach to global regulatory affairs

A flexible approach to neuropharmacology

A flexible approach to phase II-IV clinical trials

A flexible approach to toxicology and preclinical services

Antibody drug conjugates

CNS drug development

Five criteria to use when selecting a CRO for a gene therapy study

Human AME (mass balance) studies

Selecting the location of a phase I clinical trial site for EU registration

Pharmacokinetic studies in patients

Plasma protein binding

RNAi therapeutics

Three lessons to help accelerate pharmaceutical breakthroughs for CNS disorders

Regulatory considerations in gene and cellular therapy development

Therapeutic oligonucleotide metabolite identification, profiling, and quantitation

A flexible approach to biotherapeutics and vaccines

The art behind good filtration: How to get the best out of filtration

RNA therapeutics: A revolution empowered by ddPCR™ technology

Automating cell line development for biologics: A complete guide

Effectiveness of CRISPR-Cas9 using pools of Dharmacon Edit-R synthetic crRNAs in high-content analysis screening experiments

The Dual Screen: Parallel genome-wide CRISPRi & CRISPRa screening

Pooled Phenotypic CRISPR Screening enables the identification of synergistic drug combinations for cancer therapy

Resources Filter